Biotechnology company Biogen says it plans to spin off its hemophilia business into a separate, publicly traded company. … Click to Continue »
Business News | MiamiHerald.com &, Miami Herald: Business
Tue, 05/03/2016 - 5:02am
Biotechnology company Biogen says it plans to spin off its hemophilia business into a separate, publicly traded company. … Click to Continue »